APA (7th ed.) Citation

M, C., I, S., V, P., R, B., M, L., C, M., . . . I, M. (2022). [Adverse effects and complications of continuous intestinal infusion of levodopa-carbidopa in a cohort of patients with Parkinson's disease in a tertiary hospital]. Revista de neurologia, 74(5), 143. https://doi.org/10.33588/rn.7405.2021482

Chicago Style (17th ed.) Citation

M, Campins-Romeu, Sastre-Bataller I, Pons-Beltrán V, Baviera-Muñoz R, Losada-López M, Morata-Martínez C, Pérez-García J, and Martínez-Torres I. "[Adverse Effects and Complications of Continuous Intestinal Infusion of Levodopa-carbidopa in a Cohort of Patients with Parkinson's Disease in a Tertiary Hospital]." Revista De Neurologia 74, no. 5 (2022): 143. https://doi.org/10.33588/rn.7405.2021482.

MLA (9th ed.) Citation

M, Campins-Romeu, et al. "[Adverse Effects and Complications of Continuous Intestinal Infusion of Levodopa-carbidopa in a Cohort of Patients with Parkinson's Disease in a Tertiary Hospital]." Revista De Neurologia, vol. 74, no. 5, 2022, p. 143, https://doi.org/10.33588/rn.7405.2021482.